Benjamin Lab

Benjamin Lab Group

CVC In the News

The State of Heart Research
Milwaukee's NPR radio program Lake Effect speaks with Ivor Benjamin, MD, Director of the MCW Cardiovascular Center about the state of cardiovascular research and the national push to train the general population in CPR and the use of automated external defibrilators (AEDs).

Ivor J. Benjamin MD, FAHA, FACC Ivor Benjamin, MD, FAHA, FACC

Director, Cardiovascular Center
Professor, Department of Medicine
Froedtert & Medical College of Wisconsin

Ivor J. Benjamin MD, FAHA, FACC, is a Professor of Medicine at Froedtert Hospital, and the Medical College of Wisconsin. A board-certified specialist and consultant in internal medicine and cardiology, Dr. Benjamin’s clinical interests are general cardiology, inheritable heart failure, and myocardial infarction.

Qiang Dai, PhD, MCW CVC Benjamin Lab Qiang Dai, PhD

Research Associate II

Our laboratory has longstanding interests in the role that stress response (HSF/HSP) pathways play in the development, progression, and, ultimately, the prevention of acquired and inheritable cardiac diseases. My studies of genetically engineered mouse models and somatic cell cultures are exploring the mechanisms underlying the effects of genetic, metabolic (e.g., redox), and other perturbations in ischemic cardioprotection and heart failure.

Shuping Lai, PhD, MCW CVC Benjamin LabShuping Lai, PhD

Research Associate II

My research project aims on modeling cardiac diseases in a culture dish by utilizing patient specimens. We are creating cardiomyocytes from human induced pluripotent stem cells, differentiate them into cardiomyocytes and use them as a means to mimic the disease in a dish. My major interests are drug-screenings and biochemical assays to exhibit different susceptibilities of cardiac cells to cardiac drugs, to predict adverse drug responses more accurately and to find best suitable drugs for cardiac diseases.

Kurt Kolander, MCW CVC Benjamin Lab Kurt Kolander

Postdoctoral Fellow

My current project is focused on studying atrial fibrillation. Using both transgenic rats, and human induced pluripotent stem cells, my goal is to develop systems to elucidate the mechanisms of atrial fibrillation and to test the efficacy of treatments for this disorder. This work will hopefully contribute to the development of personalized treatments for atrial fibrillation and other heart diseases.

Elizabeth SchiblyElizabeth Schibly

Former Trainees

  • Melinda Choi | Second-Year Medical Student (MSII), Medical College of Wisconsin
  • Katie Mitzelfelt, PhD | Postdoctoral Fellow, University of Washington, Dr. Chuck Murry's Laboratory
  • Mai Thao, PhD | Senior Chemist, Medtronic